Mylan Q3 Profit Tops Estimates; Lifts 2014 Adj. EPS Guidance - Quick Facts

(RTTNews) - Mylan Inc. (MYL) reported that its third-quarter net earnings attributable to shareholders increased to $499.1 million or $1.26 per share from $158.9 million or $0.40 per share, last year. Adjusted earnings per share was $1.16 for the quarter.

On average, ten analysts polled by Thomson Reuters expected the company to report profit per share of $1.14 for the quarter. Analysts' estimates typically exclude special items.

Total revenues were $2.08 billion, compared to $1.77 billion, a year ago. Analysts expected revenue of $2.06 billion for the quarter.

Mylan increased its 2014 full year guidance range for adjusted EPS to $3.54 to $3.60. The guidance excludes potential launches of generic Copaxone and generic Lidoderm. Analysts expect the company to report full year profit per share of $3.49.

Mylan expects fourth quarter adjusted EPS in the range of $1.03 to $1.09. Analysts expect the company to report fourth-quarter earnings per share of $1.00.